Lygature announces Peter Luijten as chairman of Board of Directors

Peter Luijten brings years of experience in the public and private sector, and was Chief Scientific Officer of CTMM from 2008 to 2015. He is Professor of Functional Medical Imaging at UMC Utrecht, Vice Dean at Utrecht Life Sciences, and until recently President of the Imaging & Oncology Division at UMC Utrecht. In addition, he has worked for over 20 years in various (international) leadership roles at Philips Medical Systems.

Peter Luijten: "It is fantastic to see how Lygature has developed into a unique and crucial player in the Dutch and European knowledge infrastructure. I look forward to working with the Lygature Board to further develop the organization into a sustainable partner for operationalizing public-private partnerships across the full spectrum of life sciences: from fundamental research to clinical trials and market approval, patient participation and regulatory innovation."

Lygature’s Managing Director, Jorg Janssen: "We are very pleased that Peter, with his scientific track record, has agreed to take on this role. It strengthens our position as a partnership management organization with scientific depth in the field of medicine and medical technology. It enables Lygature to continue to grow as a valued player in the European life sciences & health innovation ecosystem."

The Lygature Board consists of representatives from different groups active in public-private collaborations. In addition to Peter Luijten, the current board consists of:

• Hans van Eenennaam (Entrepreneur and co-inventor of Keytruda)
• Ida Haisma (Director Leiden Bio Science Park)
• Marian Joëls (Dean UMC Groningen and professor Neurosciences)
• Gerjan Kemperman (Entrepreneur and founder of ChemConnection which became part of Ardena, currently co-owner and COO Ardena)
• Michel Rudolphie (Independent consultant and former director of Dutch Cancer Society)